BASi Expands Business Development Team in US and Canada
News Jul 15, 2009
BASi announces the expansion of their business development team in the United States. Don Hawker will represent BASi in Canada and the Western U.S. covering California, Oregon, Washington, Idaho, Nevada, Utah, Montana, Arizona and Wyoming.
Hawker's sales and marketing background will be an asset to expanding BASi’s contract research services (preclinical, bioanalytical, large molecule bioanalysis, method development, pharmaceutical analysis) and specialized instrumentation and accessories for electrochemistry and in vivo sampling products.
Hawker brings an extensive background in sales and marketing in the life sciences industry, including GLP large and small molecule bioanalysis, proteomics, bioinformatics, GMP bioanalytical and more.
“Don’s unique blend of business development, sales and marketing experiences gives BASi a definite advantage,” stated BASi Vice President of Sales and Marketing, Jon Brewer. “Don maintains excellent relationships with key scientists, technology assessment and outsourcing professionals in large pharma and biotech organizations – that will give him a head start on his work for BASi.”
Changing Lanes: Algorithm Helps AI Drive More Like HumansNews
For self-driving cars, algorithms for changing lanes are beset by one of two problems. Either, they rely on detailed statistical models of the driving environment, which are too complex to analyze on the fly; or they’re so simple that they can lead to impractically conservative decisions, such as never changing lanes at all. Now a new algorithm hopes to split the difference, allowing aggressive lane changes than the simple models do but relies only on immediate information about other vehicles’ directions and velocities to make decisions.
Bicycle Therapeutics Expands Strategic Partnership with AstraZenecaNews
New programs added in respiratory and cardio-metabolic diseases.READ MORE
Worldwide Clinical Trials Receives 2018 CRO Leadership AwardsNews
Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018